Previous close | 1.0000 |
Open | 1.2000 |
Bid | 1.0300 |
Ask | 1.4200 |
Strike | 126.00 |
Expiry date | 2024-06-28 |
Day's range | 1.1500 - 1.2000 |
Contract range | N/A |
Volume | |
Open interest | 20 |
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
Moderna stock is trading sideways despite a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?